{"id":"single-dose-of-cannabis-oil","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2107910","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanisms of cannabis oil are complex and multifaceted, involving the interaction of various cannabinoids with cannabinoid receptors in the brain and body. This interaction can lead to a range of therapeutic effects, including pain relief, reduced inflammation, and improved mood.","oneSentence":"Cannabis oil modulates the endocannabinoid system to produce therapeutic effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:34:47.873Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic pain management"},{"name":"Nausea and vomiting associated with chemotherapy"}]},"trialDetails":[{"nctId":"NCT05261321","phase":"PHASE1","title":"Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2022-10-15","conditions":"Healthy","enrollment":20},{"nctId":"NCT04816994","phase":"PHASE3","title":"Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2018-01-07","conditions":"Acute Radicular Back Pain, Cannabis","enrollment":200},{"nctId":"NCT06807762","phase":"PHASE1","title":"Safety and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare","status":"RECRUITING","sponsor":"GreenCare Pharma","startDate":"2025-03-18","conditions":"Healthy","enrollment":72},{"nctId":"NCT05092191","phase":"PHASE2","title":"Cannabis as a Complementary Treatment in Multiple Sclerosis","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2022-11-10","conditions":"Multiple Sclerosis","enrollment":250},{"nctId":"NCT06526208","phase":"PHASE2","title":"Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults","status":"NOT_YET_RECRUITING","sponsor":"Southwest Autism Research & Resource Center","startDate":"2024-10-01","conditions":"Autism Spectrum Disorder, Anxiety","enrollment":108},{"nctId":"NCT02283281","phase":"PHASE2, PHASE3","title":"Anesthetic Premedication With a Cannabis Extract (Cannapremed)","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2015-05","conditions":"Pain, Postoperative, Postoperative Nausea and Vomiting, Anxiety","enrollment":200},{"nctId":"NCT05344170","phase":"PHASE1, PHASE2","title":"Cannabinol Use in Patients With Insomnia Disorder","status":"COMPLETED","sponsor":"Woolcock Institute of Medical Research","startDate":"2022-08-24","conditions":"Insomnia Disorder","enrollment":20},{"nctId":"NCT00681538","phase":"PHASE3","title":"A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2008-01","conditions":"Spasticity, Multiple Sclerosis","enrollment":572},{"nctId":"NCT01610700","phase":"PHASE3","title":"An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2001-05","conditions":"Multiple Sclerosis","enrollment":160},{"nctId":"NCT04261166","phase":"PHASE1","title":"A Phase I Open Label Study to Assess PK and Safety of Plant Cannabis Extract","status":"COMPLETED","sponsor":"Breath of Life International Pharma Ltd","startDate":"2019-07-24","conditions":"Healthy","enrollment":76},{"nctId":"NCT04808531","phase":"PHASE3","title":"NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers","status":"UNKNOWN","sponsor":"Medlab Clinical","startDate":"2023-11","conditions":"Cancer Related Pain","enrollment":360},{"nctId":"NCT03717272","phase":"PHASE2","title":"Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects","status":"COMPLETED","sponsor":"Aelis Farma","startDate":"2018-10-23","conditions":"Marijuana Abuse","enrollment":29},{"nctId":"NCT03883360","phase":"PHASE2","title":"Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2050-01","conditions":"Schizophrenia Spectrum Disorders, Cannabis Use","enrollment":""},{"nctId":"NCT04841993","phase":"PHASE1","title":"Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2018-12-10","conditions":"Cannabis Use, Healthy Subjects","enrollment":43},{"nctId":"NCT04601207","phase":"PHASE1","title":"A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population","status":"COMPLETED","sponsor":"New Age Ventures LLC","startDate":"2020-06-19","conditions":"Healthy, Cannabis","enrollment":32},{"nctId":"NCT02240160","phase":"PHASE1","title":"A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects","status":"TERMINATED","sponsor":"GW Pharmaceuticals Ltd","startDate":"2014-08","conditions":"Healthy Volunteers","enrollment":6},{"nctId":"NCT01975688","phase":"PHASE1","title":"A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis","status":"TERMINATED","sponsor":"GW Pharmaceuticals Ltd","startDate":"2014-02","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Single-dose of cannabis oil","genericName":"Single-dose of cannabis oil","companyName":"Hadassah Medical Organization","companyId":"hadassah-medical-organization","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cannabis oil modulates the endocannabinoid system to produce therapeutic effects. Used for Chronic pain management, Nausea and vomiting associated with chemotherapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}